and for targeted
therapy of age-associated pathologies, including malignant neoplasms. In this regard, the study
Пути развития иммунотерапии колоректального рака for clonal evolution and the development of chemoresistance. Therefore, the most rational
combination Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Takhirova, Z.R.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2023) characteristic for the Russian cohort and to the complexity of replication of data reported for the
combined